Die Bolusinjektion von anisoyliertem Plasminogen-Streptokinase-Aktivator-Komplex (BRL 26921) als alternatives Konzept der systemischen Lyse bei akutem Myokardinfarkt
- 1 August 1986
- journal article
- abstracts
- Published by Springer Nature in Klinische Wochenschrift
- Vol. 64 (15), 682-687
- https://doi.org/10.1007/bf01712052
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Comparison of the hypotensive effects of streptokinase-(human) plasmin activator complex and BRL 26921 (p-anisoylated streptokinase-plasminogen activator complex) in the dog after high dose, bolus administrationThrombosis Research, 1984
- Thrombolytic TherapyNew England Journal of Medicine, 1984
- Intravenous streptokinase in evolving acute myocardial infarctionThe American Journal of Cardiology, 1984
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Intravenous short-term infusion of streptokinase in acute myocardial infarction.Circulation, 1983
- Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapyNature, 1981
- Effects of coronary artery reperfusion on myocardial infarct size and survival in conscious dogs.Circulation, 1981
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977
- The Modified Gauss-Newton Method for the Fitting of Non-Linear Regression Functions by Least SquaresTechnometrics, 1961